Top

Published in:

01-02-2014 | News and Views

The heterogeneity of ovarian cancer

Authors: I. Meinhold-Heerlein, S. Hauptmann

Published in: Archives of Gynecology and Obstetrics | Issue 2/2014

Abstract

Ovarian cancer carries the worst prognosis of all gynecological malignancies. This is mainly due to its resistance against commonly used cytostatic drugs as well as the lack of a screening method for its detection at an early stage. Both basic and translational research have shown over the past decades that ovarian cancer as a medical term includes several types of tumors with different phenotypes, molecular biology, etiology, tumor progression, and even different prognosis. In this issue of Archives of Gynecology and Obstetrics, J. Dietel presents a review article about novel findings of the etiopathogenesis of ovarian cancer and the role that fallopian tubes may play. He also outlines the implied clinical consequences. Here, we give a brief overview of the heterogeneity of ovarian cancer to introduce the topic.

Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164(5):1511–1518PubMedCrossRef

Du Bois A, Ewald-Riegler N et al (2009) Borderline-Tumoren des Ovars—eine systematische übersicht. Geburtsh Frauenheilk 69:807–833CrossRef

Seidman JD, Kurman RJ (2000) Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 31(5):539–557PubMedCrossRef

Kurman RJ, Shih Ie M (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34(3):433–443PubMedCentralPubMedCrossRef

Kurman RJ, Shih Ie M (2008) Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27(2):151–160PubMedCentralPubMed

Heintz AP, Odicino F et al (2006) Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):161–192CrossRef

Meinhold-Heerlein I, Bauerschlag D et al (2005) Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene 24(6):1053–1065PubMedCrossRef

Fleming JS, Beaugie CR et al (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247(1–2):4–21PubMedCrossRef

Jazaeri AA (2009) Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease. Mol Oncol 3(2):151–156PubMedCrossRef

10.

Bauerschlag DO, Schem C et al (2009) The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer. J Cancer Res Clin Oncol 136(1):79–88CrossRef

11.

Hauptmann S, Denkert C et al (2002) Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum Pathol 33(6):632–641PubMedCrossRef

12.

Shih Ie M, Kurman RJ (2005) Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res 11(20):7273–7279PubMedCrossRef

13.

Hennessy BT, Coleman RL et al (2009) Ovarian cancer. Lancet 374(9698):1371–1382PubMedCrossRef

Title: The heterogeneity of ovarian cancer
Authors: I. Meinhold-Heerlein
S. Hauptmann
Publication date: 01-02-2014
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 2/2014
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-013-3114-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The heterogeneity of ovarian cancer

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2014

The mode of delivery in patients with preeclampsia at term subject to elective or emergency Cesarean section

Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma

Female patients with pseudomyxoma peritonei: a single-institution clinicopathologic study of 35 cases

Low-dose methotrexate treatment in ectopic pregnancy: a retrospective analysis of 164 ectopic pregnancies treated between 2000 and 2008

Expression and localization of maspin in cervical cancer and its role in tumor progression and lymphangiogenesis

Association of serum estradiol levels on the day of hCG administration with pregnancy rates and embryo scores in fresh ICSI/ET cycles down regulated with either GnRH agonists or GnRH antagonists